Anales De Medicina Interna最新文献_第8页

[The importance of A1 and B apoproteins as cardiovascular risk markers]. A1和B载脂蛋白作为心血管危险标志物的重要性。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400013

F M Sánchez, M I Albo Castaño, S Casallo Blanco, A Vizuete Calero, L de Matías Salces

引用次数: 1

[Tolerance to celecoxib and meloxicam in patients with intolerance to nonsteroidal anti-inflammatory drugs]. [非甾体抗炎药不耐受患者对塞来昔布和美洛昔康的耐受性]。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400003

S Vázquez-Cortés, L Vázquez-Fuertes, M Rodríguez-Alvarez, I Reig Rincón de Arellano, C Martínez-Cócera

{"title":"[Tolerance to celecoxib and meloxicam in patients with intolerance to nonsteroidal anti-inflammatory drugs].","authors":"S Vázquez-Cortés, L Vázquez-Fuertes, M Rodríguez-Alvarez, I Reig Rincón de Arellano, C Martínez-Cócera","doi":"10.4321/s0212-71992008000400003","DOIUrl":"https://doi.org/10.4321/s0212-71992008000400003","url":null,"abstract":"Introduction: Hypersensitive reactions to analgesics in the general population are less than 1%. Previous studies have demonstrated that cyclooxigenase 2 (COX-2) inhibitors are an efficient alternative in patients with non-steroidal anti-inflammatory drugs (NSAIDs) intolerance. The aim of our study is to test the tolerance to celecoxib and meloxicam in patients with NSAIDs intolerance, upto dosages higher than those used in previous studies.Material and methods: The subjects of the study were 38 NSAID-sensitive patients from September 2004 to June 2005. The diagnosis of intolerance to NSAIDs was carried out by means of single-blind placebo-controlled oral challenge with aspirin. We performed single-blind placebo controlled oral challenge tests with celecoxib (accumulated dose of 400 mg) and meloxicam (accumulated dose of 15 mg).Results: There was only one reaction with celecoxib (97.3%) which was generalised urticaria after the dose of 400 mg accumulated, it should be pointed out that this patient tolerated perfectly the dose of 200 mg. For meloxicam, we found 100% tolerance at a dosage of 15 mg, including the patient who showed a reaction to the celecoxib.Conclusion: We consider that there are patients with tolerance to low dosages of COX-2 inhibitors who show a reaction on increasing the administered dosage, which means that their tolerance should be taken into account and checked in the long term.","PeriodicalId":50798,"journal":{"name":"Anales De Medicina Interna","volume":"25 4","pages":"163-7"},"PeriodicalIF":0.0,"publicationDate":"2008-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37432459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 7

[Hypersensitivity syndrome due to oxcarbazepine]. [奥卡西平致过敏综合征]。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400014

J M Hernández Pérez, C E Hernández García

引用次数: 0

[Approximation to palliative care in the advanced non-malignant diseases]. [晚期非恶性疾病的缓和治疗近似值]。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400009

R Navarro Sanz, C López Almazán

{"title":"[Approximation to palliative care in the advanced non-malignant diseases].","authors":"R Navarro Sanz, C López Almazán","doi":"10.4321/s0212-71992008000400009","DOIUrl":"https://doi.org/10.4321/s0212-71992008000400009","url":null,"abstract":"Nowadays Palliative Medicine (PM) is changing from a specific point of view towards patients with advanced cancer, to another more generic that also keep in mind patients with advanced non malignant disease. Likewise it is more and more deeply rooted customs that the end-of-life care has become a fundamental right of our Society. But as a matter of fact, these patients with non-cancer diseases unusually go into a Palliative Care (PC) programme. It is known the difficulty to diagnosis the end of life clinical condition (EOLCC) in them. In this article we comment the justification and restriction of PC in patients with non-malignant cancer diseases, as well as the paradoxical situation to come out, in spite of the increasing programes of PC gradually. But above all we propose in a practical way resolve when a patient with non malignant organ advanced disease (NMOAD) could be subsidiary of PC. For that purpose we have to know the diagnosis and the prognostic factors in connection with the EOLCC of the NMOAD more common (advanced chronical pulmonary disease, advanced chronical heart failure, advanced cirrhosis hepatic, advanced chronical renal failure and very evolved dementia), to set up an appropriate make decisions keeping in mind the preferences and wishes of the patient and family, to document and record in the clinical history all those parameters and offerer to the patient the treatment more suitable with the intention to get a worthy death bearing in mind clinical, cultural and ethical standards. It is pointed out the necessity to carry out prospective studies to help setting up some inclusion criterions in PC programmes for patients with NMOAD.","PeriodicalId":50798,"journal":{"name":"Anales De Medicina Interna","volume":"25 4","pages":"187-91"},"PeriodicalIF":0.0,"publicationDate":"2008-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37431863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 19

[Tumor markers in acute exacerbations of pulmonary fibrosis]. [肺纤维化急性加重期的肿瘤标志物]。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400015

J Monterrubio Villar, A Córdoba López

引用次数: 1

[Characteristics and management of epileptic seizures in emergency department and diagnostic correlation at discharge]. [急诊科癫痫发作的特点、处理及出院诊断相关性]。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400004

G Piñol-Ripoll, J Gómez Bitrian, I de la Puerta González-Miró, R Royo Hernández, J A Mauri-Llerda

{"title":"[Characteristics and management of epileptic seizures in emergency department and diagnostic correlation at discharge].","authors":"G Piñol-Ripoll, J Gómez Bitrian, I de la Puerta González-Miró, R Royo Hernández, J A Mauri-Llerda","doi":"10.4321/s0212-71992008000400004","DOIUrl":"https://doi.org/10.4321/s0212-71992008000400004","url":null,"abstract":"Background: Patients with seizures are common in the emergency department (ED), yet little is known regarding the management of these patients. This study was performed to define the demographic characteristics of patients with seizure disorders in the ED patient population and to determine final disposition, diagnostic and therapeutic activities, and to evaluate the concordance between provisional and definitive diagnosis.Material and methods: We recorded prospectively all patients which were diagnosed of seizure in ED of Hospital Clínico of Zaragoza between November 1th and April 30th. Chart review was used to gather definitive diagnosis regarding these patients.Results: Of the 54,022 patients who presented to the ED during the study period, 137 (0.36%) had complains related to seizures. Sixty one (44%) of these patients were admitted to the hospital. New-onset seizures were thought to be present in 60% of patients. Blood work was abnormal in 12% of patients and 48% of patients had pathological findings in neuroimaging study. False positive diagnosis was present in 33% of patients. The most important trigger of seizures in epileptic patients was tapped suddenly the antiepileptic drug treatment.Conclusions: We found a false positive diagnosis in 33% of patients, and the most important confounding pathology was sincope and stroke. High percentaje of pathological findings in neuroimaging studies were found. Electroencefalographic and toxicological studies were performed less than is recommended.","PeriodicalId":50798,"journal":{"name":"Anales De Medicina Interna","volume":"25 4","pages":"168-72"},"PeriodicalIF":0.0,"publicationDate":"2008-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37432460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

[Congenital heart diseases and sports]. [先天性心脏病和运动]。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400010

E Martínez Quintana, J Agredo Muñoz, F Rodríguez González, V Nieto Lago

引用次数: 1

[Breast cancer metastases in the iris: does treatment modifies natural history of the illness?]. [乳腺癌虹膜转移:治疗是否会改变疾病的自然病史?]。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400006

J A Pérez-Fidalgo, J Vila Arteaga, I Chirivella González, R Martínez Belda, B Bermejo de Lasheras, S Roselló Keranën, A Fons Moreno, A Lluch Hernández

引用次数: 3

[Middle cerebral artery ischemic stroke presentation of miliar tuberculosis]. [脑中动脉缺血性卒中常见结核的表现]。

Anales De Medicina Interna Pub Date : 2008-04-01 DOI: 10.4321/s0212-71992008000400007

B Zalba Etayo, B Obón Azuara, I Gutiérrez Cía, B Villanueva Anadón, R Ridruejo Sáez

引用次数: 0

[Pleural effusion associated with diclofenac]. [双氯芬酸引起的胸腔积液]。

Anales De Medicina Interna Pub Date : 2008-03-01 DOI: 10.4321/s0212-71992008000300015

F J Nicolás-Sánchez, R M Sarrat-Nuevo, L Fernández-Cabrera, J Cabau-Rubies

引用次数: 0